Trump's address, SpaceX IPO, Sam's Club membership prices and more in Morning Squawk

Oil jumped roughly 8% after President Trump said the U.S. could 'hit' Iran's oil and vowed to strike Iran 'extremely hard' over the next 2-3 weeks, sending stock futures lower in a clear risk-off move. SpaceX has confidentially filed for an IPO and could seek about a $1.75 trillion valuation with a potential June listing, while Eli Lilly received FDA approval for its once-daily GLP-1 pill Foundayo (shipping next week; $25/month with coupon or up to $349 without). Sam's Club raised annual membership by $10 to $60/$120 and Congressional Republicans backed a two-track DHS funding approach, leaving immigration enforcement for later debate.

Analysis

A geopolitical-driven risk repricing is compressing risk assets and widening energy-market implied volatility; that dynamic favors holders of oil optionality and penalizes short-duration, high-beta exposures over the next 2–6 weeks when headline noise and thin holiday liquidity amplify gap risk. Second-order, higher energy transport and logistics costs will feed into grocery and discretionary margins with a 6–12 month lag — companies with membership/loyalty revenue (sticky, recurring cash flow) will see smaller churn versus basket-dependent retailers.

The GLP‑1 pill rollout accelerates channel bifurcation: DTC launch + couponing forces manufacturers to trade higher initial volume for lower realized net price, compressing near-term EBITDA per new patient but expanding total addressable market. That increases contestability for incumbents with differentiated economies of scale in manufacturing and payer contracting; expect market share battles to be decided by PBM formulary wins and rebate structures over 3–12 months, not just product efficacy headlines.

A marquee IPO from a capital-starved tech platform would reallocate institutional demand and could temporarily depress other late-stage tech valuations; rotation risk is acute during the IPO window as index-eligible flows, lockups, and Musk-linked correlated selling can create cross-asset liquidity squeezes. Separately, large-scale reallocation into AI R&D at legacy software vendors creates near-term margin risk but raises medium-term product stickiness — an asymmetric setup for active, event-driven trades.

Given the calendar (jobs data ahead, holiday-thinned markets) hedge instruments and calendar-sensitive option structures dominate efficient risk control. Key near-term catalysts to watch: payrolls and unemployment, DHS funding developments, and first month of GLP‑1 DTC sales data — each can swing sentiment materially within days but typically resolves into secular share-shifts over months.

Key Decisions for Investors

• Buy short-dated energy call spreads (e.g., XLE 30–45 day 1x1 call spread) to capture elevated crude volatility with defined risk. Target entry: within next 48 hours while implied vols remain elevated; position size 2–4% notional of tactical book. Reward: captures a ~15–40% up-move in energy ETF with limited downside to premium paid.
• Pairs trade GLP‑1 competition: Long LLY 6–9 month call (or buy-call spread) funded by selling NVO 6–9 month calls (strike slightly OTM) to express share-shift to Lilly while capping capital. Timeframe: 6–12 months to let formulary and payer reactions materialize. Risk: capped by sold calls; upside if Lilly converts DTC demand into durable payer wins.
• Consumer retail pair: Long WMT (cash or 3–6 month call spread) vs short COST (equivalent notional short or buy-put spread) to play membership elasticity and price-sensitive spending. Entry: size 1–2% net long equity exposure; horizon 3–9 months to capture membership monetization and share gains. Stop: 8–10% adverse move intraday or fundamental catalyst reversing thesis.
• Event hedge and volatility trade: Buy 2–4 week ATM SPX puts or small VIX call package ahead of the jobs print and thin holiday liquidity to protect equity portfolio tails. Keep hedge size to cover 3–5% portfolio drawdown; unwind within 48–72 hours post-release unless job data confirms a regime shift.
• Short ORCL duration risk via 3–6 month put spread or short into strength before earnings given elevated AI capex and near-term margin pressure. Keep position size limited (1–2% book) and set stop if implied vol collapses by >30% or company issues explicit runway guidance improvement.